Actinium Pharmaceuticals, Inc. (ATNM)
1.22
+0.03
(+2.52%)
USD |
NYAM |
Sep 18, 16:00
1.21
-0.01
(-0.82%)
After-Hours: 20:00
Actinium Pharmaceuticals Total Assets (Quarterly) : 40.16M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 40.16M |
| March 31, 2026 | 45.44M |
| December 31, 2025 | 52.21M |
| September 30, 2025 | 56.15M |
| June 30, 2025 | 63.02M |
| March 31, 2025 | 68.65M |
| December 31, 2024 | 76.90M |
| September 30, 2024 | 82.11M |
| June 30, 2024 | 89.86M |
| March 31, 2024 | 88.35M |
| December 31, 2023 | 81.44M |
| September 30, 2023 | 88.94M |
| June 30, 2023 | 99.05M |
| March 31, 2023 | 102.03M |
| December 31, 2022 | 114.19M |
| September 30, 2022 | 116.82M |
| June 30, 2022 | 121.80M |
| March 31, 2022 | 74.56M |
| December 31, 2021 | 80.39M |
| September 30, 2021 | 84.48M |
| June 30, 2021 | 84.45M |
| March 31, 2021 | 75.10M |
| December 31, 2020 | 66.40M |
| September 30, 2020 | 50.53M |
| June 30, 2020 | 55.96M |
| Date | Value |
|---|---|
| March 31, 2020 | 8.364M |
| December 31, 2019 | 11.67M |
| September 30, 2019 | 16.32M |
| June 30, 2019 | 21.82M |
| March 31, 2019 | 12.24M |
| December 31, 2018 | 14.89M |
| September 30, 2018 | 15.70M |
| June 30, 2018 | 22.58M |
| March 31, 2018 | 28.14M |
| December 31, 2017 | 18.34M |
| September 30, 2017 | 21.72M |
| June 30, 2017 | 12.98M |
| March 31, 2017 | 18.24M |
| December 31, 2016 | 22.53M |
| September 30, 2016 | 17.26M |
| June 30, 2016 | 21.57M |
| March 31, 2016 | 23.34M |
| December 31, 2015 | 26.59M |
| September 30, 2015 | 25.05M |
| June 30, 2015 | 26.33M |
| March 31, 2015 | 20.06M |
| December 31, 2014 | 7.569M |
| September 30, 2014 | 12.60M |
| June 30, 2014 | 15.45M |
| March 31, 2014 | 6.560M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Anika Therapeutics, Inc. | 183.47M |
| Savara, Inc. | 192.14M |
| Vericel Corp. | 502.87M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 9.855M |
| Shareholders Equity (Quarterly) | 30.30M |
| Debt to Equity Ratio | 0.0443 |
| Current Ratio | 4.076 |
| Net Debt Paydown Yield | 0.06% |